Advances in Liquid Biopsy for Early Cancer Detection: A Comprehensive Review of Circulating Tumor DNA and Other Biomarkers
Introduction Cancer remains a leading cause of morbidity and mortality worldwide, with projections indicating a substantial escalation in burden over the coming decades [1]. In 2023, approximately 18.5 million new cases and 10.4 million deaths occurred globally, excluding non-melanoma skin cancers, with forecasts suggesting rises to around 30.5 million new cases and 18.6 million deaths … Read more